scispace - formally typeset
P

Per Nilsson

Researcher at Karolinska Institutet

Publications -  114
Citations -  9816

Per Nilsson is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 25, co-authored 82 publications receiving 7340 citations. Previous affiliations of Per Nilsson include RIKEN Brain Science Institute & Karolinska University Hospital.

Papers
More filters
Journal ArticleDOI

Probability, rate and timing of reconstructive surgery following colectomy for inflammatory bowel disease in Sweden: a population-based cohort study.

TL;DR: The aim of this study was to investigate the probability, rate and timing of reconstructive surgery after colectomy in patients with IBD in a population‐based setting.
Journal ArticleDOI

Pelvic local recurrence from colorectal cancer: surgical challenge with changing preconditions.

TL;DR: Evaluated determinants associated with outcomes after surgery for pelvic LR and how these have changed over time show how the rate of local recurrence after colorectal cancer surgery has decreased.
Journal ArticleDOI

Tobacco use and cancer survival: A cohort study of 40,230 Swedish male construction workers with incident cancer

TL;DR: A history of tobacco use, even exclusive use of the seemingly benign snus, is associated with moderately increased cancer‐specific mortality, and although nicotine might play a role, the mechanisms warrant further investigation.
Journal ArticleDOI

Preoperative treatment selection in rectal cancer: A population-based cohort study

TL;DR: The use of preoperative (chemo-) radiotherapy increased over time and suboptimal adherence to guidelines appears to exist leading to a risk of overtreatment and to a small extent also undertreatment.
Journal ArticleDOI

Age-related changes in brain phospholipids and bioactive lipids in the APP knock-in mouse model of Alzheimer’s disease

TL;DR: The authors used an APP knock-in (App-KI) AD mouse that accumulates β-amyloid (Aβ) and presents cognitive deficits (at 2 and 6 months of age, respectively) to investigate LMs, their precursors, biosynthetic enzymes and receptors, glial activation, and inflammatory proteins in the cerebral cortex and hippocampus at 2, 4, 8, and 18-month-old in comparison with wild-type (WT) mice.